胎儿测序中ACMG 59个次要发现基因是否应报告的争议
基因组测序越来越多用于超声结构异常胎儿的遗传诊断,但可能检出与检测指征无关的次要发现。ACMG指南建议产后测序时报告59个可干预基因的次要发现,但明确排除产前测序。本文报道关于产前是否应报告这59个基因致病发现的辩论,辩论前多数支持报告,辩论后无显著共识,略微多数(55%)仍支持报告,表明该领域需进一步研究和制定基于证据的产前指南。
要点
- ACMG指南建议产后测序报告59个可干预基因的次要发现,但明确排除产前测序。
- 产前是否报告这59个基因的致病发现存在争议,辩论后55%的听众仍支持报告。
- 该领域需进一步研究并制定适用于产前家系测序的循证指南。
核心结论
- 产前测序是否应报告ACMG 59个基因的次要发现尚无显著共识,辩论后55%的听众支持报告。
研究设计与样本
- 本文为关于产前测序是否应报告ACMG 59个基因次要发现的辩论报道,未报告系统检索或样本量。
主要发现
- 辩论前更多听众支持报告,但无显著共识;辩论后听众倾向不报告,但55%仍支持报告。
关键数值与推荐
- ACMG指南建议产后测序时报告59个基因的次要发现,这些基因的致病变异可能导致可预防或治疗的疾病,并允许选择退出。
- ACMG指南明确排除产前测序。
临床怎么用
- 产前测序中报告ACMG 59个基因的次要发现需谨慎,应结合父母意愿和临床情境个体化决策。
- 当前证据不足以形成产前测序次要发现的统一报告标准,建议参与研究或遵循机构规范。
局限性
- 本文仅为辩论报道,未提供系统评价或原始研究数据,共识基于听众投票。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genome sequencing is increasingly being used to aid genetic diagnosis in fetuses with structural abnormalities detected on ultrasound examination. However, with clinical exome and genome sequencing, there is potential for the recognition and reporting of incidental or secondary findings unrelated to the indication for ordering the sequencing, but of potential medical value for patient care. In the postnatal setting, the American College of Medical Genetics and Genomics (ACMG) has clear guidelines that state that when offering sequencing, secondary findings should be reported in 59 genes for which ACMG consider there is a clinical evidence that pathogenic variants may result in disease that might be prevented or treated, with the option to opt out of receiving this information. However, these guidelines specifically exclude prenatal sequencing. Here, we report the debate on whether or not pathogenic findings in these 59 genes should or should not be reported in the prenatal setting. Although more were in favour of reporting before the debate, there was no significant consensus from the audience. After the debate there was a swing toward not reporting, but a slim majority (55%) remained in favour, indicating that this is an area requiring further research and the development of evidence-based guidelines applicable to prenatal proband and trio sequencing.
引用
- Amor DJ, Chitty LS, Van den Veyver IB, et al. Current controversies in prenatal diagnosis 2: The 59 genes ACMG recommends reporting as secondary findings when sequencing postnatally should be reported when detected on fetal (and parental) sequencing. Prenat Diagn. 2020. PMID: 32091628. doi:10.1002/pd.5670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。